Compounds as c-Met kinase inhibitors
US8664244B2 · kind B2 · utility
12Cited by
0References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 8, 2011 |
| Grant date | Mar 4, 2014 |
| Priority date | — |
| Expiry date | Jan 8, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds, processes for their preparation, pharmaceutical compositions containing them as active ingredient, methods for the treatment of disease states associated with the inhibition of the protein tyrosine kinase activity of growth factor receptors such as c-Met, thereby making them useful as anticancer agents, to their use as medicaments for use in the production of inhibition of tyrosine kinases reducing effects in warm-blooded animals such as humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.